•  
  •  
  •  
  •  

2025-06-25 10:29:22

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Philogen provides update on Marketing Authorization application for Nidlegy™ in the European Union
  • Star Health Insurance partners with Medi Assist to transform claims through AI and Digital Innovation
  • Winro Commercial India Ltd to make investment in anchor portion of HDB Financial Services Ltd IPO
  • Supreme Infrastructure India Ltd receives contract worth Rs. 450 crore
  • CarTrade Labs to Drive Innovation and Shape the Future of Technology

Keywords Selected:  NathBioGenesIndia

Stock Report

  • Nath Bio-Genes India Ltd Q4 FY25 consolidated net profit slips to Rs. 1.48 crore
  • Nath Bio-Genes India Ltd Q3 FY25 consolidated profit increases QoQ to Rs. 2.65 crore
  • Nath Bio-Genes India Ltd Q2 FY2024-25 consolidated profit at Rs. 1.11 crore
  • Nath Bio-Genes India Ltd recommends dividend of Rs. 2
  • Nath Bio-Genes India Ltd Q4 FY24 consolidated profit at Rs. 2.61 crore
  • Nath Bio-Genes India Ltd Q3 FY2024 consolidated net profit rises to Rs. 3.81 crores
  • Nath Bio-Genes India Limited recommends dividend of Rs. 2
  • Nath Bio-Genes India Ltd posts Rs. 1.43 crore consolidated PAT in Q4 FY2022-23
  • Nath Bio-Genes India Ltd Q2FY23 net profit at Rs. 1.46 crore
  • Nath Bio-Genes India Ltd Q1 FY2022-23 net profit at Rs. 30.75 crores
  • Nath Bio-Genes India Q3FY22 net profit at Rs. 2.80 crores
  • Nath Bio-Genes India Ltd Q2FY22 profit slides to Rs. 1.23 crore

Latest Post

  • Philogen provides update on Marketing Authorization application for Nidlegy™ in the European Union
  • Star Health Insurance partners with Medi Assist to transform claims through AI and Digital Innovation
  • Winro Commercial India Ltd to make investment in anchor portion of HDB Financial Services Ltd IPO
  • Supreme Infrastructure India Ltd receives contract worth Rs. 450 crore
  • CarTrade Labs to Drive Innovation and Shape the Future of Technology


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024